• レポートコード:20QY06-06494 • 出版社/出版日:QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、135ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品・医療 |
Single User | ¥600,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥900,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、充血除去剤のグローバル市場について種類別(錠剤、カプセル剤、点鼻薬)、用途別(病院、研究・研究所、クリニック、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・充血除去剤市場の概要 ・世界の主要地域別充血除去剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の充血除去剤市場規模2015-2026:種類別(錠剤、カプセル剤、点鼻薬) ・世界の充血除去剤市場規模2015-2026:用途別(病院、研究・研究所、クリニック、その他) ・充血除去剤の北米市場規模2015-2020 ・充血除去剤のヨーロッパ市場規模2015-2020 ・充血除去剤の中国市場規模2015-2020 ・充血除去剤の日本市場規模2015-2020 ・充血除去剤の東南アジア市場規模2015-2020 ・充血除去剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 (Mylan N.V.、Teva Pharmaceutical Industries Ltd.、Ranbaxy Laboratories Ltd.、Beximco Pharmaceuticals Ltd.、Novartis AG、Cipla Ltd.) ・充血除去剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・充血除去剤の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Decongestant Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Decongestant market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Decongestant is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Decongestant market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Decongestant industry.
Based on our recent survey, we have several different scenarios about the Decongestant YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Decongestant will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Decongestant market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Decongestant market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Decongestant market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Decongestant market. The report also includes nautical information, where it shows Decongestant market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Decongestant market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Decongestant market.
Geographical Analysis:
Based on region, the global Decongestant market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Decongestant market are
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Ranbaxy Laboratories Ltd.
Beximco Pharmaceuticals Ltd.
Novartis AG
Cipla Ltd.
…
Segment by Type
Tablets
Capsules
Nasal Sprays
Segment by Application
Hospitals
Research & Academic Laboratories
Clinic
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Decongestant market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Decongestant market.
• The market share of the global Decongestant market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Decongestant market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Decongestant market.
1 Decongestant Market Overview
1.1 Decongestant Product Scope
1.2 Decongestant Segment by Type
1.2.1 Global Decongestant Sales by Type (2020-2026)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Nasal Sprays
1.3 Decongestant Segment by Application
1.3.1 Global Decongestant Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Research & Academic Laboratories
1.3.4 Clinic
1.3.5 Other
1.4 Decongestant Market Estimates and Forecasts (2015-2026)
1.4.1 Global Decongestant Sales Growth Rate (2015-2026)
1.4.2 Global Decongestant Revenue and Growth Rate (2015-2026)
1.4.3 Global Decongestant Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Decongestant Industry Impact
1.5.1 How the Covid-19 is Affecting the Decongestant Industry
1.5.1.1 Decongestant Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Decongestant Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Decongestant Players to Combat Covid-19 Impact
2 Decongestant Estimate and Forecast by Region
2.1 Global Decongestant Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Decongestant Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Decongestant Sales Market Share by Region (2015-2020)
2.2.2 Global Decongestant Revenue Market Share by Region (2015-2020)
2.3 Global Decongestant Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Decongestant Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Decongestant Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Decongestant Estimates and Projections (2015-2026)
2.4.2 Europe Decongestant Estimates and Projections (2015-2026)
2.4.3 China Decongestant Estimates and Projections (2015-2026)
2.4.4 Japan Decongestant Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Decongestant Estimates and Projections (2015-2026)
2.4.6 India Decongestant Estimates and Projections (2015-2026)
3 Global Decongestant Competition Landscape by Players
3.1 Global Top Decongestant Players by Sales (2015-2020)
3.2 Global Top Decongestant Players by Revenue (2015-2020)
3.3 Global Decongestant Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Decongestant as of 2019)
3.4 Global Decongestant Average Price by Company (2015-2020)
3.5 Manufacturers Decongestant Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Decongestant Players (Opinion Leaders)
4 Global Decongestant Market Size by Type
4.1 Global Decongestant Historic Market Review by Type (2015-2020)
4.1.1 Global Decongestant Sales Market Share by Type (2015-2020)
4.1.2 Global Decongestant Revenue Market Share by Type (2015-2020)
4.1.3 Global Decongestant Price by Type (2014-2020)
4.2 Global Decongestant Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Decongestant Sales Forecast by Type (2021-2026)
4.2.2 Global Decongestant Revenue Forecast by Type (2021-2026)
4.2.3 Global Decongestant Price Forecast by Type (2021-2026)
5 Global Decongestant Market Size by Application
5.1 Global Decongestant Historic Market Review by Application (2015-2020)
5.1.1 Global Decongestant Sales Market Share by Application (2015-2020)
5.1.2 Global Decongestant Revenue Market Share by Application (2015-2020)
5.1.3 Global Decongestant Price by Application (2015-2020)
5.2 Global Decongestant Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Decongestant Sales Forecast by Application (2021-2026)
5.2.2 Global Decongestant Revenue Forecast by Application (2021-2026)
5.2.3 Global Decongestant Price Forecast by Application (2021-2026)
3 North America Decongestant Market Facts & Figures
3.2 North America Decongestant Sales Market Share by Company (2015-2020)
3.3 North America Decongestant Sales Market Share by Type (2015-2020)
3.4 North America Decongestant Sales Market Share by Application (2015-2020)
4 Europe Decongestant Market Facts & Figures
4.2 Europe Decongestant Sales Market Share by Company (2015-2020)
4.3 Europe Decongestant Sales Market Share by Type (2015-2020)
4.4 Europe Decongestant Sales Market Share by Application (2015-2020)
5 China Decongestant Market Facts & Figures
5.2 China Decongestant Sales Market Share by Company (2015-2020)
5.3 China Decongestant Sales Market Share by Type (2015-2020)
5.4 China Decongestant Sales Market Share by Application (2015-2020)
6 Japan Decongestant Market Facts & Figures
6.2 Japan Decongestant Sales Market Share by Company (2015-2020)
6.3 Japan Decongestant Sales Market Share by Type (2015-2020)
6.4 Japan Decongestant Sales Market Share by Application (2015-2020)
7 Southeast Asia Decongestant Market Facts & Figures
7.2 Southeast Asia Decongestant Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Decongestant Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Decongestant Sales Market Share by Application (2015-2020)
8 India Decongestant Market Facts & Figures
8.2 India Decongestant Sales Market Share by Company (2015-2020)
8.3 India Decongestant Sales Market Share by Type (2015-2020)
8.4 India Decongestant Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Decongestant Business
12.1 Mylan N.V.
12.1.1 Mylan N.V. Decongestant Corporation Information
12.1.2 Mylan N.V. Decongestant Business Overview and Total Revenue
12.1.3 Mylan N.V. Decongestant Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Mylan N.V. Decongestant Products Offered
12.1.5 Mylan N.V. Recent Development
12.2 Teva Pharmaceutical Industries Ltd.
12.2.1 Teva Pharmaceutical Industries Ltd. Decongestant Corporation Information
12.2.2 Teva Pharmaceutical Industries Ltd. Decongestant Business Overview and Total Revenue
12.2.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Pharmaceutical Industries Ltd. Decongestant Products Offered
12.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.3 Ranbaxy Laboratories Ltd.
12.3.1 Ranbaxy Laboratories Ltd. Decongestant Corporation Information
12.3.2 Ranbaxy Laboratories Ltd. Decongestant Business Overview and Total Revenue
12.3.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Ranbaxy Laboratories Ltd. Decongestant Products Offered
12.3.5 Ranbaxy Laboratories Ltd. Recent Development
12.4 Beximco Pharmaceuticals Ltd.
12.4.1 Beximco Pharmaceuticals Ltd. Decongestant Corporation Information
12.4.2 Beximco Pharmaceuticals Ltd. Decongestant Business Overview and Total Revenue
12.4.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Beximco Pharmaceuticals Ltd. Decongestant Products Offered
12.4.5 Beximco Pharmaceuticals Ltd. Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Decongestant Corporation Information
12.5.2 Novartis AG Decongestant Business Overview and Total Revenue
12.5.3 Novartis AG Decongestant Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis AG Decongestant Products Offered
12.5.5 Novartis AG Recent Development
12.6 Cipla Ltd.
12.6.1 Cipla Ltd. Decongestant Corporation Information
12.6.2 Cipla Ltd. Decongestant Business Overview and Total Revenue
12.6.3 Cipla Ltd. Decongestant Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Cipla Ltd. Decongestant Products Offered
12.6.5 Cipla Ltd. Recent Development
…
13 Decongestant Manufacturing Cost Analysis
13.1 Decongestant Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Decongestant
13.4 Decongestant Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Decongestant Distributors List
14.3 Decongestant Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Decongestant Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Decongestant Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Decongestant Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Decongestant Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Decongestant Players to Combat Covid-19 Impact
Table 8. Global Market Decongestant Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Decongestant Sales (MT) by Region (2015-2020)
Table 10. Global Decongestant Sales Market Share by Region (2015-2020)
Table 11. Global Decongestant Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Decongestant Revenue Share by Region (2015-2020)
Table 13. Global Decongestant Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Decongestant Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Decongestant Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Decongestant Revenue Share Forecast by Region (2021-2026)
Table 17. Global Decongestant (MT) of Key Companies (2015-2020)
Table 18. Global Decongestant Sales Share by Company (2015-2020)
Table 19. Global Decongestant Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Decongestant Revenue Share by Company (2015-2020)
Table 21. Global Decongestant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Decongestant as of 2019)
Table 22. Global Decongestant Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Decongestant Manufacturing Sites and Area Served
Table 24. Manufacturers Decongestant Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Decongestant Players
Table 27. Global Decongestant Sales (MT) by Type (2015-2020)
Table 28. Global Decongestant Sales Share by Type (2015-2020)
Table 29. Global Decongestant Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Decongestant Price (MT) by Type (2015-2020)
Table 31. Global Decongestant Sales Share by Type (2021-2026)
Table 32. Global Decongestant Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Decongestant Revenue Share by Type (2021-2026)
Table 34. Global Decongestant Price (MT) by Type (2021-2026)
Table 35. Global Decongestant Sales (MT) by Application (2015-2020)
Table 36. Global Decongestant Sales Share by Application (2015-2020)
Table 37. Global Decongestant Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Decongestant Price (MT) by Application (2015-2020)
Table 39. Global Decongestant Sales (MT) by Application (2021-2026)
Table 40. Global Decongestant Sales Share by Application (2021-2026)
Table 41. Global Decongestant Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Decongestant Revenue Share by Application (2021-2026)
Table 43. Global Decongestant Price (MT) by Application (2021-2026)
Table 44. United States Decongestant Sales (MT) by Company (2015-2020)
Table 45. United States Decongestant Sales Market Share by Company (2015-2020)
Table 46. United States Decongestant Sales (MT) by Type (2015-2020)
Table 47. United States Decongestant Sales Market Share by Type (2015-2020)
Table 48. United States Decongestant Sales (MT) by Application (2015-2020)
Table 49. United States Decongestant Sales Market Share by Application (2015-2020)
Table 50. Europe Decongestant Sales (MT) by Company (2015-2020)
Table 51. Europe Decongestant Sales Market Share by Company (2015-2020)
Table 52. Europe Decongestant Sales (MT) by Type (2015-2020)
Table 53. Europe Decongestant Sales Market Share by Type (2015-2020)
Table 54. Europe Decongestant Sales (MT) by Application (2015-2020)
Table 55. Europe Decongestant Sales Market Share by Type (2015-2020)
Table 56. China Decongestant Sales (MT) by Company (2015-2020)
Table 57. China Decongestant Sales Market Share by Company (2015-2020)
Table 58. China Decongestant Sales (MT) by Type (2015-2020)
Table 59. China Decongestant Sales Market Share by Type (2015-2020)
Table 60. China Decongestant Sales (MT) by Application (2015-2020)
Table 61. China Decongestant Sales Market Share by Application (2015-2020)
Table 62. Japan Decongestant Sales (MT) by Company (2015-2020)
Table 63. Japan Decongestant Sales Market Share by Company (2015-2020)
Table 64. Japan Decongestant Sales (MT) by Type (2015-2020)
Table 65. Japan Decongestant Sales Market Share by Type (2015-2020)
Table 66. Japan Decongestant Sales (MT) by Application (2015-2020)
Table 67. Japan Decongestant Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Decongestant Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Decongestant Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Decongestant Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Decongestant Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Decongestant Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Decongestant Sales Market Share by Application (2015-2020)
Table 74. India Decongestant Sales (MT) by Company (2015-2020)
Table 75. India Decongestant Sales Market Share by Company (2015-2020)
Table 76. India Decongestant Sales (MT) by Type (2015-2020)
Table 77. India Decongestant Sales Market Share by Type (2015-2020)
Table 78. India Decongestant Sales (MT) by Application (2015-2020)
Table 79. India Decongestant Sales Market Share by Application (2015-2020)
Table 80. Mylan N.V. Corporation Information
Table 81. Mylan N.V. Description and Business Overview
Table 82. Mylan N.V. Decongestant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Mylan N.V. Decongestant Product
Table 84. Mylan N.V. Recent Development
Table 85. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 86. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 87. Teva Pharmaceutical Industries Ltd. Decongestant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceutical Industries Ltd. Decongestant Product
Table 89. Teva Pharmaceutical Industries Ltd. Recent Development
Table 90. Ranbaxy Laboratories Ltd. Corporation Information
Table 91. Ranbaxy Laboratories Ltd. Description and Business Overview
Table 92. Ranbaxy Laboratories Ltd. Decongestant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Ranbaxy Laboratories Ltd. Decongestant Product
Table 94. Ranbaxy Laboratories Ltd. Recent Development
Table 95. Beximco Pharmaceuticals Ltd. Corporation Information
Table 96. Beximco Pharmaceuticals Ltd. Description and Business Overview
Table 97. Beximco Pharmaceuticals Ltd. Decongestant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Beximco Pharmaceuticals Ltd. Decongestant Product
Table 99. Beximco Pharmaceuticals Ltd. Recent Development
Table 100. Novartis AG Corporation Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Decongestant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Novartis AG Decongestant Product
Table 104. Novartis AG Recent Development
Table . Cipla Ltd. Corporation Information
Table . Cipla Ltd. Description and Business Overview
Table . Cipla Ltd. Decongestant Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Cipla Ltd. Decongestant Product
Table . Cipla Ltd. Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Decongestant Distributors List
Table 113. Decongestant Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Decongestant Product Picture
Figure 2. Global Decongestant Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Decongestant Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Research & Academic Laboratories Examples
Figure 8. Clinic Examples
Figure 9. Other Examples
Figure 10. Global Decongestant Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Decongestant Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Decongestant Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 13. Global Decongestant Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Decongestant Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Decongestant Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Decongestant Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Decongestant Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Decongestant Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Decongestant Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Decongestant Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Decongestant Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Decongestant Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Decongestant Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Decongestant Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Decongestant Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Decongestant Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Decongestant Players Market Share by Revenue in Decongestant 2015 & 2019
Figure 28. Decongestant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Decongestant Revenue Share by Type (2015-2020)
Figure 30. Global Decongestant Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Decongestant Revenue Share by Application (2015-2020)
Figure 32. Global Decongestant Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Decongestant Sales Market Share by Type in 2019
Figure 34. United States Decongestant Sales Market Share by Type in 2019
Figure 35. Europe Decongestant Sales Market Share by Company in 2019
Figure 36. Europe Decongestant Sales Market Share by Type in 2019
Figure 37. Europe Decongestant Sales Market Share by Application in 2019
Figure 38. China Decongestant Sales Market Share by Company in 2019
Figure 39. China Decongestant Sales Market Share by Type in 2019
Figure 40. China Decongestant Sales Market Share by Application in 2019
Figure 41. Japan Decongestant Sales Market Share by Company in 2019
Figure 42. Japan Decongestant Sales Market Share by Type in 2019
Figure 43. Japan Decongestant Sales Market Share by Application in 2019
Figure 44. Southeast Asia Decongestant Sales Market Share by Company in 2019
Figure 45. Southeast Asia Decongestant Sales Market Share by Type in 2019
Figure 46. Southeast Asia Decongestant Sales Market Share by Application in 2019
Figure 47. India Decongestant Sales Market Share by Company in 2019
Figure 48. India Decongestant Sales Market Share by Type in 2019
Figure 49. India Decongestant Sales Market Share by Application in 2019
Figure 50. Mylan N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ranbaxy Laboratories Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Beximco Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Cipla Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Decongestant
Figure 58. Manufacturing Process Analysis of Decongestant
Figure 59. Decongestant Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed